The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction

BACKGROUND: DA-8010 is a novel compound developed for the treatment of overactive bladder (OAB) and urinary incontinence. The aims of this study were to investigate the effects of DA-8010 on OAB in a rat model. METHODS: Study animals were divided into the following five groups of seven animals each:...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Bong, Jeon, Seung Hwan, Kwon, Eun Bi, Bae, Woong Jin, Cho, Hyuk Jin, Ha, U-Syn, Hong, Sung-Hoo, Lee, Ji Youl, Kim, Sae Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164290/
https://www.ncbi.nlm.nih.gov/pubmed/32303205
http://dx.doi.org/10.1186/s12894-020-00611-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164290/
https://www.ncbi.nlm.nih.gov/pubmed/32303205
http://dx.doi.org/10.1186/s12894-020-00611-8

Ejemplares similares